Original article—alimentary tractSmall Intestinal Bacterial Overgrowth in Rosacea: Clinical Effectiveness of Its Eradication
Section snippets
Patients and Controls
This is a prospective study involving 113 consecutive rosacea patients (82 women, 31 men; mean age, 52 ± 15 years) recruited in an academic dermatologic department and 60 healthy, sex- and age-matched controls (40 women, 20 men; mean age, 49 ± 11 years). Two patients had flushing, 27 had erythrosis, and 84 had papulopustules. Two patients with papulopustular rosacea exhibited also phymata. Most patients associated 2 or more phases (Table 1).
Dermatologic Assessment
Two independent dermatologists (F.D., A.P.) evaluated
Results
Baseline blood and stool analyses were normal in all patients and controls.
A significantly increased prevalence of SIBO was found in patients with rosacea compared with controls (52/113 vs 3/60, respectively; P < .001). In 40 of 52, both LH-BT and G-BT were positive, whereas G-BT only was positive in the remaining 12 cases.
Seven patients presented both SIBO and Hp infection. When stratified for cutaneous lesions, 42 of 98 patients with flush and/or erythrosis were SIBO-positive versus 10 who
Discussion
This study demonstrates that rosacea patients have a significantly higher SIBO prevalence than controls, and, more importantly, that the eradication of SIBO induces an almost complete regression of the cutaneous lesions in rosacea patients and maintains this excellent result for at least 9 months. In fact, in 78% of our patients, skin lesions fully cleared and in 17.7% improved greatly 1 month after interrupting rifaximin therapy. Moreover, all rosacea patients who remained unchanged with
References (34)
- et al.
Rosacea: I—etiology, pathogenesis, and subtype classification
J Am Acad Dermatol
(2004) - et al.
Small-bowel disease in rosacea
Lancet
(1965) - et al.
Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome
Am J Gastroenterol
(2000) - et al.
Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies
J Am Acad Dermatol
(2003) The red face
Clin Dermatol
(1993)- et al.
Small intestine bacterial overgrowth
Gastroenterology
(1979) - et al.
Glucose-H2 breath test for small intestine bacterial overgrowth
Gastroenterology
(1990) - et al.
An epidemiological study of rosacea
Acta Derm Venereol
(1989) The management of rosacea
Am J Clin Dermatol
(2002)Clinical practice: rosacea
N Engl J Med
(2005)
Helicobacter pylori in patients with rosacea
Am J Gastroenterol
Gastrointestinal observations in rosacea
Lancet
Rosacea and ulcerative colitis: a possible association
J Clin Gastroenterol
Rosacea fulminans in a patient with Crohn's disease: a case report and review of the literature
Acta Derm Venereol
A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients whith rosacea
Am J Gastroenterol
Remission of rosacea induced by reduction of gut transit time
Clin Exp Dermatol
Bacterial overgrowth
Am J Gastroenterol
Cited by (160)
Intestinal bacterial, fungal, and methanogen overgrowth
2023, Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions, Second EditionOral and external intervention on the crosstalk between microbial barrier and skin via foodborne functional component
2022, Journal of Functional FoodsCitation Excerpt :Moreover, a study indicated the potential pathogenetic effect of SIBO on the pathology of rosacea. Rosacea patients have a significantly higher morbidity rate of SIBO than that of in healthy individual (Parodi et al., 2008). The symptoms of patients with rosacea improved after successful treatment of SIBO (Weiss and Katta, 2017).
3.39 - Rosacea and Microbiome
2022, Comprehensive Gut MicrobiotaProbiotics and skin health
2022, Probiotics: Advanced Food and Health ApplicationsSmall intestinal bacterial overgrowth in patients with rosacea: prevalence and clinical features
2024, Chinese Journal of Dermatology
Prof Aurora Parodi and Prof Vincenzo Savarino are supported by the Italian Ministry of University.